Human Cytomegalovirus Infection in Women With Preexisting Immunity: Sources of Infection and Mechanisms of Infection in the Presence of Antiviral Immunity

Overview

Journal J Infect Dis

Publisher Oxford University Press

Specialty Infectious Diseases

Date 2020 Mar 6

PMID 32134479

Citations 17

Authors

William J Britt

Affiliations

Soon will be listed here.

Abstract

Human cytomegalovirus (HCMV) infection remains an important cause of neurodevelopmental sequelae in infants infected in utero. Unique to the natural history of perinatal HCMV infections is the occurrence of congenital HCMV infections (cCMV) in women with existing immunity to HCMV, infections that have been designated as nonprimary maternal infection. In maternal populations with a high HCMV seroprevalence, cCMV that follows nonprimary maternal infections accounts for 75%-90% of all cases of cCMV infections as well as a large proportion of infected infants with neurodevelopmental sequelae. Although considerable effort has been directed toward understanding immune correlates that can modify maternal infections and intrauterine transmission, the source of virus leading to nonprimary maternal infections and intrauterine transmission is not well defined. Previous paradigms that included reactivation of latent virus as the source of infection in immune women have been challenged by studies demonstrating acquisition and transmission of antigenically distinct viruses, a finding suggesting that reinfection through exposure to an exogenous virus is responsible for some cases of nonprimary maternal infection. Additional understanding of the source(s) of virus that leads to nonprimary maternal infection will be of considerable value in the development and testing of interventions such as vaccines designed to limit the incidence of cCMV in populations with high HCMV seroprevalence.

Citing Articles

Spatial kinetics and immune control of murine cytomegalovirus infection in the salivary glands.

Byrne C, Marquez A, Cai B, Coombs D, Gantt S PLoS Comput Biol. 2024; 20(8):e1011940.

PMID: 39150988 PMC: 11357091. DOI: 10.1371/journal.pcbi.1011940.

Inhibition of human cytomegalovirus entry into mucosal epithelial cells.

He L, Hertel L, James C, Morgan I, Klingelhutz A, Fu T Antiviral Res. 2024; 230:105971.

PMID: 39074588 PMC: 11408113. DOI: 10.1016/j.antiviral.2024.105971.

Human cytomegalovirus microRNAs: strategies for immune evasion and viral latency.

Sabbaghian M, Gheitasi H, Fadaee M, Javadi Henafard H, Tavakoli A, Shekarchi A Arch Virol. 2024; 169(8):157.

PMID: 38969819 DOI: 10.1007/s00705-024-06080-w.

Re-Evaluating Human Cytomegalovirus Vaccine Design: Prediction of T Cell Epitopes.

Barry P, Iyer S, Gibson L Vaccines (Basel). 2023; 11(11).

PMID: 38005961 PMC: 10674879. DOI: 10.3390/vaccines11111629.

Modeling and Remodeling the Cell: How Digital Twins and HCMV Can Elucidate the Complex Interactions of Viral Latency, Epigenetic Regulation, and Immune Responses.

McMahon-Cole H, Johnson A, Aghamiri S, Helikar T, Crawford L Curr Clin Microbiol Rep. 2023; 10(3):141-151.

PMID: 37901689 PMC: 10601359. DOI: 10.1007/s40588-023-00201-w.

References

Deere J, Chang W, Villalobos A, Schmidt K, Deshpande A, Castillo L . Neutralization of rhesus cytomegalovirus IL-10 reduces horizontal transmission and alters long-term immunity. Proc Natl Acad Sci U S A. 2019; 116(26):13036-13041. PMC: 6601001. DOI: 10.1073/pnas.1903317116. View

Gardner T, Tortorella D . Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick Getaway. Microbiol Mol Biol Rev. 2016; 80(3):663-77. PMC: 4981668. DOI: 10.1128/MMBR.00018-16. View

Yamamoto A, Mussi-Pinhata M, Boppana S, Novak Z, Wagatsuma V, Oliveira P . Human cytomegalovirus reinfection is associated with intrauterine transmission in a highly cytomegalovirus-immune maternal population. Am J Obstet Gynecol. 2010; 202(3):297.e1-8. PMC: 8351475. DOI: 10.1016/j.ajog.2009.11.018. View

Baraniak I, Kern F, Holenya P, Griffiths P, Reeves M . Original Antigenic Sin Shapes the Immunological Repertoire Evoked by Human Cytomegalovirus Glycoprotein B/MF59 Vaccine in Seropositive Recipients. J Infect Dis. 2019; 220(2):228-232. PMC: 6581893. DOI: 10.1093/infdis/jiz089. View

Nikitskaya E, Lebedeva A, Ivanova O, Maryukhnich E, Shpektor A, Grivel J . Cytomegalovirus-Productive Infection Is Associated With Acute Coronary Syndrome. J Am Heart Assoc. 2016; 5(8). PMC: 5015295. DOI: 10.1161/JAHA.116.003759. View

Pokalyuk C, Renzette N, Irwin K, Pfeifer S, Gibson L, Britt W . Characterizing human cytomegalovirus reinfection in congenitally infected infants: an evolutionary perspective. Mol Ecol. 2016; 26(7):1980-1990. DOI: 10.1111/mec.13953. View

Murph J, Souza I, Dawson J, Benson P, Petheram S, Pfab D . Epidemiology of congenital cytomegalovirus infection: maternal risk factors and molecular analysis of cytomegalovirus strains. Am J Epidemiol. 1998; 147(10):940-7. DOI: 10.1093/oxfordjournals.aje.a009384. View

Hansen S, Powers C, Richards R, Ventura A, Ford J, Siess D . Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science. 2010; 328(5974):102-6. PMC: 2883175. DOI: 10.1126/science.1185350. View

Cannon M, Stowell J, Clark R, Dollard P, Johnson D, Mask K . Repeated measures study of weekly and daily cytomegalovirus shedding patterns in saliva and urine of healthy cytomegalovirus-seropositive children. BMC Infect Dis. 2014; 14:569. PMC: 4240830. DOI: 10.1186/s12879-014-0569-1. View

10.

Bale Jr J, Petheram S, Souza I, Murph J . Cytomegalovirus reinfection in young children. J Pediatr. 1996; 128(3):347-52. DOI: 10.1016/s0022-3476(96)70279-2. View

11.

Murrell I, Bedford C, Ladell K, Miners K, Price D, Tomasec P . The pentameric complex drives immunologically covert cell-cell transmission of wild-type human cytomegalovirus. Proc Natl Acad Sci U S A. 2017; 114(23):6104-6109. PMC: 5468625. DOI: 10.1073/pnas.1704809114. View

12.

Ikuta K, Minematsu T, Inoue N, Kubo T, Asano K, Ishibashi K . Cytomegalovirus (CMV) glycoprotein H-based serological analysis in Japanese healthy pregnant women, and in neonates with congenital CMV infection and their mothers. J Clin Virol. 2013; 58(2):474-8. DOI: 10.1016/j.jcv.2013.07.004. View

13.

Ross S, Arora N, Novak Z, Fowler K, Britt W, Boppana S . Cytomegalovirus reinfections in healthy seroimmune women. J Infect Dis. 2009; 201(3):386-9. PMC: 2804773. DOI: 10.1086/649903. View

14.

Pati S, Novak Z, Purser M, Arora N, Mach M, Britt W . Strain-specific neutralizing antibody responses against human cytomegalovirus envelope glycoprotein N. Clin Vaccine Immunol. 2012; 19(6):909-13. PMC: 3370452. DOI: 10.1128/CVI.00092-12. View

15.

Adachi K, Xu J, Ank B, Watts D, Mofenson L, Pilotto J . Cytomegalovirus Urinary Shedding in HIV-infected Pregnant Women and Congenital Cytomegalovirus Infection. Clin Infect Dis. 2017; 65(3):405-413. PMC: 5850431. DOI: 10.1093/cid/cix222. View

16.

Martins-Celini F, Yamamoto A, Passos D, do Nascimento S, Lima E, Di Giovanni C . Incidence, Risk Factors, and Morbidity of Acquired Postnatal Cytomegalovirus Infection Among Preterm Infants Fed Maternal Milk in a Highly Seropositive Population. Clin Infect Dis. 2016; 63(7):929-936. DOI: 10.1093/cid/ciw394. View

17.

Leruez-Ville M, Magny J, Couderc S, Pichon C, Parodi M, Bussieres L . Risk Factors for Congenital Cytomegalovirus Infection Following Primary and Nonprimary Maternal Infection: A Prospective Neonatal Screening Study Using Polymerase Chain Reaction in Saliva. Clin Infect Dis. 2017; 65(3):398-404. DOI: 10.1093/cid/cix337. View

18.

Boppana S, Rivera L, Fowler K, Mach M, Britt W . Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med. 2001; 344(18):1366-71. DOI: 10.1056/NEJM200105033441804. View

19.

Alford C, Stagno S, Pass R . Natural history of perinatal cytomegaloviral infection. Ciba Found Symp. 1979; (77):125-47. DOI: 10.1002/9780470720608.ch9. View

20.

Mussi-Pinhata M, Yamamoto A, Aragon D, Duarte G, Fowler K, Boppana S . Seroconversion for Cytomegalovirus Infection During Pregnancy and Fetal Infection in a Highly Seropositive Population: "The BraCHS Study". J Infect Dis. 2018; 218(8):1200-1204. PMC: 6129109. DOI: 10.1093/infdis/jiy321. View